Explore

Trendline Trendline
Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Product Development

Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Product Development

Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Enhance Neurocircuitry Product Development
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Growth Phase
Trendline Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Trendline Trendline
Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status
Trendline Trendline
Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment

Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment

Harbour BioMed Advances AI-Enabled Drug Candidate LET003 for Obesity Treatment
Trendline Trendline
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy

Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy

Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer to Drive Clinical Strategy
Trendline Trendline
Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing

Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing

Andelyn Biosciences Launches New Platform for Lentiviral Vector Manufacturing
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Drive Growth
Trendline Trendline
Secretome Therapeutics to Participate in Summer 2026 Investor Conferences

Secretome Therapeutics to Participate in Summer 2026 Investor Conferences

Secretome Therapeutics to Participate in Summer 2026 Investor Conferences
Trendline Trendline
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth
Trendline Trendline
Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003
Trendline Trendline
Vir Biotechnology to Present Key Data on Hepatitis Delta Treatment at EASL Congress

Vir Biotechnology to Present Key Data on Hepatitis Delta Treatment at EASL Congress

Vir Biotechnology to Present Key Data on Hepatitis Delta Treatment at EASL Congress